BioPharma APAC - Leading Source of Biopharmaceutical Intelligence in Asia Pacific

Medical Diagnostic

TiumBio and Hansoh Pharma Secure NMPA Approval for 'HS-10518/TU2670' Clinical Trial in China

TiumBio will complete the last patient dosing in a Phase 2a clinical trial of TU2670 in endometriosis in Europe by the end of the year TiumBio C...

July 06, 2023 | News

Lunit's AI Solution Impacts Radiologists' Lung Cancer Diagnosis - Published in Radiology

Findings from a recent study demonstrate that medical AI solutions with only high diagnostic accuracy can significantly improve the reading performance of ...

July 04, 2023 | News

Lumos Receives US FDA Clearance for FebriDx®

The clearance allows FebriDx to be marketed in the US for use by healthcare professionals as an aid in the diagnosis of bacterial acute respiratory infecti...

July 04, 2023 | Regulatory

Zymedi Collaborates with National Heart, Lung, and Blood Institute to Develop ZMA001 mAb for PAH Treatment

The CRADA between Zymedi and the NHLBI will enable the organizations to collaborate together to advance the development of ZMA001. Zymedi will work...

July 03, 2023 | News

Japan Approves CXR-AID for Reimbursement, Boosting Market Expansion for Lunit

Lunit (KRX:328130.KQ), a global provider of cancer diagnostics solutions, today announced that CXR-AID, FujiFilm's AI solution for chest X-ray analysis, po...

June 27, 2023 | News

Prenetics and Prof. Dennis Lo Launch US$200m Joint Venture "Insighta" for Multi-Cancer Early Detection

- Insighta is a 50/50 Joint Venture by Prenetics and Professor Dennis Lo. - Insighta is powered by technology developed by the Centre for Novostics w...

June 26, 2023 | News

Cognigenics' Intranasal CRISPR Delivery Overcomes Blood-Brain Barrier; Promising Therapeutic Breakthrough

Cognigenics CEO John L. Mee announces breakthrough results from an animal study published today in PNAS Nexus. The findings point to the pot...

June 23, 2023 | Analysis

Telix to Present ZIRCON Phase III Kidney Cancer Imaging Data at SNMMI

Further data from Telix's completed pivotal Phase III ZIRCON study of TLX250-CDx (89Zr-DFO-girentuximab) in clear cell renal cell carcinoma (ccRCC) (Clinic...

June 23, 2023 | News

Telix to Expand Late-Stage Urologic Pipeline with Acquisition of Lightpoint Medical

SENSEI is an ultra-miniature robotic gamma probe for intracavital use that is able to provide radiopharmaceutical-based surgical guidance ("radio-guided su...

June 22, 2023 | News

AWAK Technologies, Singapore General Hospital Launch Wearable Dialysis Trial

AWAK PD is a wearable and ultra-portable peritoneal dialysis (PD) system that allows patients with end-stage kidney disease to have dialysis on the go and ...

June 20, 2023 | News

SeekIn paves the way for cancer early detection in low- and middle-income countries

The overall accuracy of TOO prediction in the true positives is 66.8%, which may be supportive in the clinical diagnostic workup. OncoSeek® ...

June 19, 2023 | News

Singapore Welcomes 10,000 Global Experts for 25th World Congress of Dermatology, Focusing on Skin Research and Treatment

For the first time ever in Southeast Asia, the 25th World Congress of Dermatology (WCD2023) will take place in Singapore at S...

June 16, 2023 | News

6th Asia Dengue Summit kicks off on 15 June, in conjunction with ASEAN Dengue Day

The ASEAN region has witnessed a significant increase in dengue cases and is considered the global epicenter of dengue infections With more th...

June 15, 2023 | News

EW Group Partners with China's Sinopharm, the Largest Healthcare Provider.

EW Group represented by Chairman, Prof. Dato' Sri Dr Mike Chan, and HK VJM Ltd was represented by Mr Guo Liang, while NCL Solutions Sdn Bhd repre...

June 15, 2023 | News

Stay Connected